Insights and perspectives on the role of APOC1 inhibition in modulating immunotherapy outcomes in HCC: Commentary on Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
作者信息
Wei Jiewen
机构信息
Shantou University Medical College, Shantou, 515031, China.
出版信息
Redox Biol. 2025 Jun;83:103564. doi: 10.1016/j.redox.2025.103564. Epub 2025 Feb 25.
PMID:40339430
Abstract
摘要
Zotero 插件